RGEN May 2023 135.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:26PM EDT. Market open.
Loading interactive chart…
- Zacks
Why Is Repligen (RGEN) Down 11.4% Since Last Earnings Report?
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
WALTHAM, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 21-22. Tony J. Hunt, President and Chief Executive Officer, will participate in an analyst-led discussion on Tuesday, March 21, at 1:30 p.m. EDT. A live webcast of the presentation will be accessible through the Investor R
- Zacks
Repligen's (RGEN) Q4 Earnings and Revenues Beat Estimates
Repligen (RGEN) reports encouraging fourth-quarter and full-year 2022 results, with sales and earnings beating estimates.
© 2023 Yahoo. All rights reserved.
